Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassan Yousefi

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|February 15, 2022
Nischarin Deletion Reduces Oxidative Metabolism and Overall ATP: A Study Using a Novel <i>NISCH</i><i></i> Knockout Mouse ModelTina H Nguyen, Hassan Yousefi, Samuel C Okpechi, et al.
Inflammation|August 14, 2012
Is the IL-10 promoter polymorphism at position -592 associated with immune system-related diseases?Mojgan Noroozi Karimabad, Mohammad Kazemi Arababadi, Elham Hakimizadeh, et al.
Veterinary Research Forum : an International Quarterly Journal|January 17, 2015
Follicle stimulating hormone increases spermatogonial stem cell colonization during in vitro co-cultureReza Narenji Sani, Parviz Tajik, Mohammad Hassan Yousefi, et al.
Cancer Letters|March 19, 2021
Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancerSuman Mohajan, Praveen Kumar Jaiswal, Mousa Vatanmakarian, et al.
Oncogene|January 9, 2021
Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistanceHassan Yousefi, Mousa Vatanmakanian, Mojdeh Mahdiannasser, et al.
Scientific Reports|July 22, 2023
Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapyShengli Dong, Margarite D Matossian, Hassan Yousefi, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 5, 2020
Non-coding RNAs underlying chemoresistance in gastric cancerArash Poursheikhani, Zahra Bahmanpour, Ehsan Razmara, et al.
Molecular Cancer|January 15, 2022
Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapyReza Hosseini, Hamzeh Sarvnaz, Maedeh Arabpour, et al.
European Journal of Pharmacology|October 2, 2019
Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cellsSepideh Hamzehlou, Majid Momeny, Zahra Zandi, et al.
Life Sciences|October 29, 2021
Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cellsMajid Momeny, Sahar Shamsaiegahkani, Bahareh Kashani, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|February 15, 2022
Nischarin Deletion Reduces Oxidative Metabolism and Overall ATP: A Study Using a Novel <i>NISCH</i><i></i> Knockout Mouse ModelTina H Nguyen, Hassan Yousefi, Samuel C Okpechi, et al.
Inflammation|August 14, 2012
Is the IL-10 promoter polymorphism at position -592 associated with immune system-related diseases?Mojgan Noroozi Karimabad, Mohammad Kazemi Arababadi, Elham Hakimizadeh, et al.
Veterinary Research Forum : an International Quarterly Journal|January 17, 2015
Follicle stimulating hormone increases spermatogonial stem cell colonization during in vitro co-cultureReza Narenji Sani, Parviz Tajik, Mohammad Hassan Yousefi, et al.
Cancer Letters|March 19, 2021
Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancerSuman Mohajan, Praveen Kumar Jaiswal, Mousa Vatanmakarian, et al.
Oncogene|January 9, 2021
Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistanceHassan Yousefi, Mousa Vatanmakanian, Mojdeh Mahdiannasser, et al.
Scientific Reports|July 22, 2023
Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapyShengli Dong, Margarite D Matossian, Hassan Yousefi, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 5, 2020
Non-coding RNAs underlying chemoresistance in gastric cancerArash Poursheikhani, Zahra Bahmanpour, Ehsan Razmara, et al.
Molecular Cancer|January 15, 2022
Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapyReza Hosseini, Hamzeh Sarvnaz, Maedeh Arabpour, et al.
European Journal of Pharmacology|October 2, 2019
Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cellsSepideh Hamzehlou, Majid Momeny, Zahra Zandi, et al.
Life Sciences|October 29, 2021
Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cellsMajid Momeny, Sahar Shamsaiegahkani, Bahareh Kashani, et al.
Pageof 7